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Abstract: The European Prospective Investigation into Cancer and Nutrition (EPIC) is a multicentre
prospective study conducted in 23 centres in 10 European countries. Here we review the findings
from EPIC on the relationship between diet-related exposures and incidence or mortality from the
four most frequent cancers in the European population: colorectal, breast, lung, and prostate cancer.
We conducted a systematic review following PRISMA guidelines and identified 110 high-quality
studies based on the EPIC cohort. Fruit and vegetable consumption had a protective effect against
colorectal, breast, and lung cancer, whereas only fruit had a protective effect against prostate cancer.
A higher consumption of fish and lower consumption of red and processed meat were related with
a lower risk of colorectal cancer; and higher consumption of fatty fish with lower risk of breast
cancer. Calcium and yogurt intake were found to protect against colorectal and prostate cancer.
Alcohol consumption increased the risk for colorectal and breast cancer. Finally, adherence to the
Mediterranean diet emerged as a protective factor for colorectal and breast cancer. The EPIC study
results are in agreement with the latest evidence from leading authorities on cancer prevention and
help to inform public prevention policies and strategies.
Keywords: colorectal cancer; breast cancer; lung cancer; prostate cancer; intake; alcohol; fruits;
vegetables; meat; fish
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1. Introduction
Worldwide, an estimated 18.1 million new cancer cases (excluding nonmelanoma skin
cancer) and nearly 10 million cancer deaths occurred in 2020 [1]. In Europe, the 2020 cancer
burden was estimated to have ascended to 2.7 million new cases and 1.3 million deaths [2].
Overall, the burden of cancer incidence and mortality is rapidly growing, and although
cancer was once considered to be a disease of high-income countries, it is now one of the
most important public health problems worldwide. The increasing cancer burden reflects
in part the decline in fertility and increase of life expectancy, but also the economic, societal,
and lifestyle changes related to globalization and socioeconomic development [1,3].
Cancer is a disease characterized mainly by loss of genetic control of cell growth and
proliferation. Therefore, it is a genetic disease but the factors that originate the disease
process are mainly attributable to environmental and lifestyle factors. These include
tobacco consumption, diet, excessive body weight and obesity, alcohol consumption,
physical inactivity, or sun exposure, among others, meaning there is great potential for
cancer prevention [4–6]. In relation to modifiable lifestyle factors, there is overwhelming
evidence that nutrition, diet, and other related factors such as alcohol intake, physical
activity or obesity have an important impact on cancer risk—even more so than smoking—,
and that positive behaviour changes can significantly reduce cancer burden [7,8]. However,
despite several decades of epidemiological research, the scientific evidence of the effect
of many specific foods and nutrients on cancer is still inconsistent or insufficient and
attempts to draw solid conclusions have been hampered [5,8,9]. The European Prospective
Investigation into Cancer and Nutrition (EPIC), one of the largest cohort studies in the
world, was precisely designed to investigate the relationship between diet and cancer
and other chronic diseases with the purpose of overcoming previous limitations and
contributing to the scientific body of knowledge [10,11].
EPIC is a multi-centre prospective cohort study of 519,978 participants (366,521 women
and 153,457 men), most aged 35–70 years, and recruited mostly between 1992 and 1998.
Its main aim has been to investigate the relationship of dietary, genetic, lifestyle, and
environmental factors with the incidence of cancer and other chronic diseases [5,11]. The
study was conducted in 23 centres in 10 different European countries: France, Denmark,
Germany, Italy, Greece, The Netherlands, Spain, Norway, Sweden, and the UK. Europe
is considered an ideal natural laboratory due to the different dietary habits found in the
European population. These include Mediterranean diet patterns typical of southern Italy,
Greece, the south of France, and Spain; central European food patterns typical of Germany,
the Netherlands, and the north of France; and Nordic diet patterns found in Denmark and
Sweden [10]. In addition, the incidence of some major cancers varies significantly between
countries and even between regions [10].
Diet over the previous 12 months was assessed at the time of recruitment using
validated country-specific questionnaires [12,13]: self-administered semiquantitative food-
frequency questionnaires (around 260 food items), semi-quantitative food-frequency ques-
tionnaires (combined with dietary record), and diet history questionnaires administered
through interviews (with more than 600 food items) [11]. To calibrate the dietary measure-
ment and to correct the errors produced by overestimation or underestimation of food
intake, a 24-h recall was performed by a computerized program (EPICSOFT) in a random
subsample of 8% of the cohort [14]. In addition, information about lifestyles, habits, and
medical history was collected. Weight, height, and waist and hip circumference were
assessed, and 385,747 blood samples were collected for hormonal, biochemical, and genetic
analyses. Incident cancer cases (above 109,000 cases so far) are regularly identified through
automated links with the databases of population cancer registries, except in Germany,
France, and Greece, where a combination of methods is used (including monitoring of health in-
surance records, hospital registries, and active follow-up of participants). Nutrients are analysed
using a standardised Food Composition Table (EPIC Nutrient Database ENDB) [15].
Altogether, the EPIC cohort is one of the largest worldwide and its findings regularly
contribute to international recommendations on cancer prevention. The last review of the
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evidence based on EPIC regarding the role of diet in cancer prevention was published more
than 10 years ago [9]. Multiple publications with longer follow-up and investigating pre-
viously unaddressed diet-related exposures have been published ever since, significantly
increasing the contribution of EPIC. Thus, the aim of the current review is to summarize
the findings derived from the EPIC study regarding the relationship between diet-related
exposures and cancer risk and mortality, considering the four most frequent cancer types
in the European population [1]: colorectal, breast, lung, and prostate cancer.
2. Materials and Methods
This study was reported following the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA guidelines) (Figure 1) [16] and was registered in
the International Prospective Register of Systematic Reviews PROSPERO (Registration
number: CRD42021245178).
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow
diagram of study selection, inclusion and exclusion.
2.1. Search Strategy
We systematically searched MEDLINE (via PubMed), Scopus, and Web of Science to
identify prospective studies from the European Prospective Investigation into Cancer and
Nutrition (EPIC) study addressing the effect of diet-related factors on the incidence and
mortality of colorectal, breast, lung, and prostate cancer. The search strategy included the
following terms: (“European prospective investigation into cancer” OR “European prospec-
tive investigation into cancer and nutrition” OR “EPIC study”) AND (“lung cancer” OR
“prostate cancer” OR “breast cancer” OR “colorectal cancer” OR “colon cancer” OR “rectal
cancer”) AND (“diet” OR “intake” OR “nutrients”). The literature search was performed
between February and March 2021 by reviewing citations of the articles considered eligible
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for the systematic review, and the authors were contacted to obtain missing information when
necessary. The complete search strategies used for each database are available in Table S1.
2.2. Study Selection
The criteria for including studies were as follows: (i) study design: prospective
studies from the EPIC project; (ii) any of the following exposures: food intake/type
of diet/nutrient levels/nutritional biomarkers/alcohol consumption; and (iii) outcome:
incidence or mortality of colorectal, breast, prostate, or lung cancer. The criteria for
excluding studies were as follows: non-eligible publication types, such as review articles,
editorials, comments, guidelines, or case reports. No exclusion criteria were applied
based on language or journal publication date. The titles, abstracts, and full texts were
independently reviewed by 2 reviewers (E.U.-G. and A.C.-L.), and disagreements were
solved by consensus or involving a third researcher.
2.3. Data Extration and Quality Assessment
The following data was extracted from the original reports: (1) first author and year of
publication; (2) tumour site; (3) no. of cases; (4) no. of non-cases; (5) mean follow-up; and
(6) main results. The Mendeley software was used for data management.
The Joanna Briggs Institute Critical Appraisal Tool for Systematic Reviews (Table S2) [17]
was used to evaluate the risk of bias for cohort studies as in previous cancer and diet
reviews [18–20]. The assessed methodological criteria included 11 items, each of them
with four possible answers: “yes” (criterion met), “no” (criterion not met), “unclear”, and
“not applicable” (N/A). A study was considered as “high quality” when the quality score
was at least 0.75 (i.e., 75%), whereas studies were considered as “low quality” when the
quality score was lower than 0.75. In addition, a score for each criterion was calculated,
by dividing the number of positively scored by the total number of included studies, to
provide an overview of how well the current literature scores on each criterion.
Data extraction and quality assessment were independently performed by two re-
searchers, and inconsistencies were solved by consensus or involving a third researcher.
2.4. Data Synthesis
Due to the overlap of participants among studies, a quantitative meta-analysis was
not undertaken. Therefore, the evidence was summarized qualitatively for each of the
included cancer types (colorectal, breast, lung, and prostate cancer). The results are shown
by type of cancer and grouped according to exposure type following the “Third Expert
Report of Diet, Nutrition, Physical Activity and Cancer: a Global Perspective, from World
Cancer Research Fund” [9].
3. Results
3.1. Study Quality
All 110 studies that entered the review (see Figure 1) were high quality studies accord-
ing to the assessment tool for Systematic Reviews from The Joanna Briggs Institute [17].
Table S3 shows the percentage of studies meeting the quality criteria and provides detailed
information on the quality score of each study.
When the studies were analysed by individual domains, 100% of the studies measured
the exposure and the outcomes in a valid and reliable manner, identified the potential
confounders and took them into account within the study design or in the data analysis,
the participants were free of the outcomes of interest at the start of the study, the follow up
was completed by a large percentage of participants, and the statistical analysis used was
appropriate. It should be taken into account that, among the studies that had two groups,
44.7% had similar groups that were recruited from the same population, and 100% of those
studies measured the exposures similarly in order to assign people to the exposed or unexposed
groups. Most of the studies presented an appropriate length of time for follow up (93.6%). In
no study was it necessary to apply strategies to address incomplete follow up.
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3.2. Colorectal Cancer
We identified 43 studies on colorectal cancer (Table 1), with a mean follow-up of
9.2 ± 4.0 years.
Wholegrains, vegetables and fruit: A higher consumption of fruits and vegetables
combined was related to a lower risk of colorectal cancer: HR 0.86 (0.75–1.00) [21], but
no consistent associations were observed for separate consumption of fruits and vegeta-
bles [21,22]. Similar findings were observed for the association between fibre consumption
and colorectal cancer: HR 0.58 (0.41–0.85) [23], HR 0.79 (0.63–0.99) [24], and HR 0.87
(0.79–0.96) per 10 g/day increase in fibre [25]. A protective effect was also observed be-
tween intake of nuts/seeds and the risk of colon cancer in women [26]: HR 0.69 (0.50–0.95),
with no associations in men.
Meat, fish, dairy products, and preservation/processing of foods: Two studies showed
a protective effect of fish intake on colorectal cancer: HR 0.88 (0.80–0.96) comparing
the highest vs. lowest quintile [27], and HR 0.69 (0.54–0.88) comparing >80 g/day vs.
<10 g/day of intake [28]. The opposite was found with regards to meat consumption as an
increase of red and processed meat consumption associated with a higher risk of colorectal
cancer: HR 1.55 (1.19–2.02) per 100-g increase [28]. Pre-diagnostic red meat, processed meat
or fibre intakes were not associated with colorectal cancer mortality; however, a marginal
trend of processed meat was detected [29]. With regards to calcium, dietary calcium intake
was associated with a lower colorectal cancer risk: IRR 0.69 (0.50–0.96) [30], and HR 0.95
(0.91–0.99) per 200 mg/day [31]. There was also an association between milk consumption
and colorectal cancer risk: HR 0.93 (0.89–0.98) per 200 g/day [31]. Finally, yogurt intake
was associated with a lower risk of colorectal cancer: HR 0.65 (0.48–0.89) [32], and HR 0.65
(0.48–0.89) [33].
Diet patterns: Adherence to the Mediterranean diet [33], the Italian Mediterranean
Index [34], and the Modified Mediterranean diet score (mMDS) [35] were found to protect
against colorectal cancer with HR 0.54 (0.36–0.81), HR 0.50 (0.35–0.71), and HR 0.89 (0.80–
0.99), respectively. In contrast, higher scores (lower nutritional quality diet) in the Food
Standards Agency nutrient profiling system dietary index (FSA-NPS DI), and higher values
in the Dietary inflammatory index (DII) were associated with a higher risk of colorectal
cancer: HR 1.11 (1.01–1.22) [36], and HR 1.15 (1.04–1.27) [37], respectively.
Alcoholic and non-alcoholic drinks: Alcohol consumption was a risk factor for col-
orectal cancer in six studies [38–43]. Of note, a HR of 1.74 (1.08–2.80) was found among
participants drinking >3 drinks/day versus those drinking <1 drink/day [38]. Alcohol
consumption (per 15-g/d increment) was associated with a higher risk of colorectal can-
cer: HR 1.05 (1.03–1.07) [39] and HR 1.08 (1.04–1.12) [42]. More specifically, the risk of
colorectal cancer was higher when drinking beer (HR 1.38, 1.08–1.77) than wine (HR 0.61–
1.21) [42,43]. Finally, total soft drink consumption was a risk factor for colorectal cancer
mortality (≥1 glass per day vs. <1 glass per month): HR 1.25 (1.07–1.47) [44].
Other dietary exposures: Several vitamins have been associated with colorectal cancer
risk. A protective effect between levels of 25-(OH)D (vitamin D) and colorectal cancer risk
was found in several publications [30,45,46]. The cancer risk associated with 10% higher
level of circulating 25-(OH)D were: HR 0.97 (0.95 to 0.99) for colorectal; HR 0.95 (0.93 to
0.98) for colon; HR 1.00 (0.97 to 1.03) for rectum [30]. Higher plasma concentrations of
vitamins B2 and B6 were associated with a lower colorectal cancer risk [47]: RR 0.71 (0.56–
0.91), and RR 0.68 (0.53–0.87), respectively. A lower colon cancer risk was associated with a
higher plasma retinol concentration and dietary b-carotene: IRR 0.63 (0.46–0.87), and OR
0.69 (0.52–0.94), respectively [48]. Dietary vitamin C and dietary vitamin E also protected
against distal colon cancer (highest vs. lowest quartile): OR 0.60 (0.39–0.93), and OR 0.65
(0.42–0.99), respectively [48]. Finally, associations with colorectal cancer were also found
for other variables such as plasma total alkyl-resorcinols [49], plasma methionine [50],
plasma choline [50], fatty acids [51], glycaemic index [33], and concentration of zinc [52],
among others.
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Table 1. Evidence synthesis of the association between diet and colorectal cancer in the EPIC study.




(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
1329 (476,711) 5.1
The data showed no association between higher intake of nuts and seeds and risk of colorectal, colon, and rectal cancers in men and women
combined, but a significant inverse association was observed in subgroup analyses for colon cancer in women at the highest (>6.2 g/d) vs. the
lowest: HR 0.69 (0.50–0.95) category of intake, and for the linear effect of log-transformed intake: HR 0.89 (0.80–0.98), with no associations in men.
Jenab 2004 [26]
1721 (518,257) 6.2 The association between fiber and colorectal cancer was significant: HR 0.79 (0.63–0.99) Bingham 2005 [24]
2819 (449,936) 8.8
Combined consumption of fruit and vegetables was inversely associated with colorectal cancer risk
(highest vs. lowest EPIC-wide quintile of consumption): HR 0.86 (0.75–1.00), P trend = 0.04.
No association between fruit or vegetable consumption was observed.
van Duijnhoven 2009 [21]
4517 (472,795) 11.0 Total dietary fibre: HR 0.87 (0.79–0.96) per 10 g/day increase in fibre. Murphy 2012 [25]
3370 (518,078) 13.0
A lower risk of colon cancer was observed with higher self-reported consumption of fruit and vegetables combined (highest vs. lowest quartile):
HR 0.87 (0.75–1.01) P trend = 0.02, but no consistent association was observed for separate consumption of fruits and vegetables. Variety in
consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer.
Leenders 2015 [22]




(YEARS) Results, Relative Risk (95% Confidence Interval (CI)) Reference
1329 (476,711) 4.8
Intake of red and processed meat: HR 1.35 (0.96–1.88) highest vs. lowest intake; P trend = 0.03
Red and processed meat calibrated: HR 1.55 (1.19–2.02); P trend = 0.001 per 100-g increase.
Intake of fish (>80 g/day vs. <10 g/day): HR 0.69 (0.54–0.88); P trend < 0.001.
Fish calibrated: HR 0.46 (0.27–0.77) P trend = 0.003 per 100-g increase.
Norat 2005 [28]
1248 (518,752) 3.9 Greater dietary intake of calcium was associated with a lower colorectal cancer risk: IRR 0.69 (0.50–0.96). Jenab 2010 [30]
861 (25,639) NR
There was an interaction between red and processed meat intake and MGMT Ile143Val polymorphism on colorectal cancer risk (P interaction = 0.04):
For individuals who carried the variant genotype with higher red and processed meat intake (above median) risk was increased:
OR 1.43 (0.82–2.48), compared with those with the common genotype and lower red and processed meat intake (below median).
Amongst the common genotype group with higher red and processed meat intake suggested an inverse association: OR 0.75 (0.55–1.01).
Loh 2010 [53]
2050 (23,490) 11.0 Dietary calcium intake was inversely but not statistically significantly associated with colorectal cancer mortality: HR for per 100 mg increase inintake 0.95 (0.88–1.02). Li 2011 [54]
289 (44,952) 12.0 Yogurt intake: HR 0.65 (0.48–0.89) highest vs. lowest tertile. Pala 2011 [32]
4513 (472,609) 11.0
Total milk consumption: HR 0.93 (0.89–0.98) per 200 g/day
Whole-fat milk: HR 0.90 (0.82–0.99) per 200 g/day
Skimmed milk: HR 0.90 (0.79–1.02) per 200 g/day
Dietary calcium: HR 0.95 (0.91–0.99) per 200 mg/day; no association observed for non-dairy calcium sources (HR 1.00, 0.81–1.24) per 200 mg/day.
Murphy 2013 [31]
421 (46,297) 11.0 Consumption of yogurt (highest vs. lowest tertile): RR 0.65 (0.48–0.89) P trend = 0.002 Sieri 2015 [33]
3789 (516,189) 4.1 Pre-diagnostic red meat, processed meat or fibre intakes (defined as quartiles and continuous grams per day) were not associated with colorectalcancer mortality among colorectal cancer survivors; however, a marginal trend across quartiles of processed meat was detected (P = 0.053). Ward 2016 [29]
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Table 1. Cont.




(YEARS) Results, Relative Risk (95% Confidence Interval (CI)) Reference
6291 (460,869) 14.9
Inversely associated with colorectal cancer incidence (highest vs. lowest quintile):
Total fish: HR 0.88 (0.80–0.96) P trend = 0.005
Fatty fish: HR 0.90 (0.82–0.98) P trend = 0.009
Lean fish: HR 0.91 (0.83–1.00) P trend = 0.016
Total n-3 LC-PUFA: HR 0.86 (0.78–0.95) P trend = 0.010
Associated with increased risk of colorectal cancer (highest vs. lowest quintile):
Dietary ratio of n-6:n-3 LC-PUFA: HR 1.31 (1.18–1.45) P trend < 0.001
Aglago 2020 [27]
1069 (469,869) 6.4
Subjects with higher concentrations of red blood cell stearic acid were at higher risk for colorectal cancer (per 1 mol%): OR 1.23 (1.07–1.42).
Conversely, colorectal cancer incidence decreased with increasing proportions of red blood cell n-3 PUFA, particularly eicosapentaenoic acid






(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
172 (99,828) 6.3 The meat-eaters pattern (meat, poultry, and margarine) was positively associated with colorectal cancer risk (highest vs. lowest quintile):RR 1.58 (0.98–2.53) P trend = 0.02 Kesse 2006 [56]
290 (63,260) NR For colorectal cancer in vegetarians compared with meat eaters: IRR 1.39 (1.01–1.91). Comparing vegetarians with nonvegetarians, the risk ofcolorectal cancer was significantly higher among vegetarians: IRR 1.49 (1.09–2.03). Key 2009 [57]
435 (44,840) 11.28
The Italian Mediterranean Index was inversely associated with colorectal cancer risk (highest vs. lowest category): HR 0.50 (0.35–0.71)
P trend = 0.043. Highest Italian
Mediterranean Index score was also significantly associated with reduced risks of any colon cancer: HR 0.54 (0.36–0.81), distal colon cancer: HR
0.44 (0.26–0.75), and rectal cancer: HR 0.41 (0.20–0.81), but not of proximal colon cancer.
Agnoli 2013 [34]
4355 (516,975) 11.6
A decreased risk of colorectal cancer was estimated when comparing the highest (scores 6–9) with the lowest (scores 0–3) adherence to the
Centre-Specific Modified Mediterranean diet score and the Modified Mediterranean diet score: HR 0.92 (0.84–1.00) and HR 0.89 (0.80–0.99), respectively.
A 2-unit increment in either Mediterranean scale was associated with a borderline statistically significant reduction in colorectal cancer risk (for
the Modified Mediterranean diet score): HR 0.96 (0.92–1.00)
Bamia 2013 [35]
421 (46,297) 11.0 Adherence to Mediterranean diet (highest vs. lowest quartile): RR 0.50 (0.35–0.71) P trend = 0.043 Sieri 2015 [33]
5806 (421,701) 15.3
A higher Food Standards Agency nutrient
profiling system dietary index (FSAm-NPS DI) score (lower nutritional quality diet) was associated with a higher risk of colorectal cancer
(highest fifth vs. lowest quintile): HR 1.11 (1.01–1.22) P trend = 0.02
Deschasaux 2018 [36]
5991(470,169) 14.0
More proinflammatory diets were related to a higher colorectal cancer risk, particularly for colon cancer:
Inflammatory Score of the Diet quartile (highest vs. lowest quintile): HR 1.15 (1.04–1.27) for colorectal cancer risk, HR 1.24 (1.09–1.41) for colon
cancer, and HR 0.99 (0.83–1.17) for rectal cancer.
Associations were more pronounced in men and not significant in women. The inflammatory profile score of the diet was associated with
colorectal cancer risk, particularly colon cancer among men (highest vs. lowest quintile): HR 1.62 (1.31–2.01) for colon cancer overall, and HR
2.11 (1.50–2.97) for colon cancer in men.
Jakszyn 2020 [37]
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Table 1. Cont.




(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
1833 (476,899) 6.2
Lifetime alcohol intake was significantly positively associated to colorectal cancer risk (for 15 g/day increase): HR 1.08 (1.04–1.12). Baseline
alcohol was significantly positively associated to colorectal cancer risk (for 15 g/day increase): HR 1.09 (1.05–1.13). The colorectal cancer risk for
beer (HR 1.38, 1.08–1.77) was higher than wine (HR 1.21, 1.02–1.44).
Ferrari 2007 [42]
407 (23,837) 11.0
Total alcohol consumption: HR 0.70 (0.44–1.13) for alcohol consumption of ≥21 units/week compared with non-drinkers; P trend = 0.14 (not
associated with colorectal cancer).
Daily consumption of ≥1 unit of wine: HR 0.61 (0.40–0.94) P trend = 0.04
Park 2009 [43]
1367 (NR) 3.6
Among individuals drinking <30 g alcohol/day (highest vs. lowest quintile of folate status):
For males: RR 0.79 (0.52–1.23) P trend = 0.19)
For females: RR 0.96 (0.67–1.37) P trend = 0.73)
Among those drinking >30 g alcohol/day (highest vs. lowest quintile of folate status):
For males: RR 0.91 (0.47–1.75) P trend = 0.87
For females: RR 2.59 (0.53–1.75) P trend = 0.47
Eussen, Vollset, Igland
2010 [41]
3759 (343,478) 12.0 Alcohol consumption: HR 0.87 (0.81–0.94) Aleksandrova 2014 [40]
NR (521,330) 16.4 Total soft drink consumption was positively associated with colorectal cancer deaths (≥1 glass per day vs. <1 glass per month): HR 1.25(1.07–1.47) P = 0.0047, with statistically non-significant associations found for sugar-sweetened and artificially sweetened soft drinks. Mullee 2019 [44]
6291 (515,039) 14.9 Greater alcohol consumption was associated with an increased risk of colorectal cancer (per 15-g/day increment): HR 1.05 (1.03–1.07). Murphy 2019 [39]





(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
1078 (518,922) 3.7
Serum C-peptide concentration was positively associated with an increased colorectal cancer risk (highest vs. lowest quintile): OR 1.37
(1.00–1.88) P trend = 0.10
The cancer risk was stronger for colon: OR 1.67 (1.14–2.46) P trend < 0.01; than for rectal cancer: OR 1.42 (0.90–2.25) P trend = 0.35
Jenab 2007 [58]
1365 (NR) 3.6
The relative risks comparing highest to lowest quintile were:
Vitamin B2: RR 0.71 (0.56–0.91) P trend = 0.02
Vitamin B6: RR 0.68 (0.53–0.87) P trend < 0.001




Folate status (highest vs. lowest quintile): RR 0.94 (0.74–1.20) P trend = 0.44
Individuals living in Northern European countries showed an inverse association between plasma folate and rectal cancer risk
(highest vs. lowest folate concentrations): RR 0.56 (0.29–1.09) P trend = 0.04
Eussen, Vollset, Igland
2010 [41]






(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
1248 (518,752) 3.9
The cancer risks associated with 10% higher level of circulating 25-(OH)D were: colorectal HR 0.97 (0.95 to 0.99); colon HR 0.95 (0.93 to 0.98);
rectum HR 1.00 (0.97 to 1.03).
Lower levels of concentration of 25-(OH)D were associated with higher colorectal cancer risk:
<25.0 nmol/L: IRR 1.32 (0.87–2.01); and 25.0–49.9 nmol/L: IRR 1.28 (1.05–1.56)
Higher concentrations of 25-(OH)D were associated with lower risk:
75.0–99.9 nmol/L: IRR 0.88 (0.68–1.13); and ≥100.0 nmol/L: 0.77 (0.56–1.06)
Jenab 2010 [30]
861 (25,639) NR
Individuals who carried the variant genotype with higher vitamin E intake had a lower OR of 0.46 (0.26–0.82) whereas those with lower vitamin
E intake had an OR of 1.46 (0.98–2.18) compared with those with the common genotype and lower vitamin E intake (P interaction = 0.009).
Similarly, the variant genotype group with higher intake of carotene had an inverse association for colorectal cancer in contrast to the common
genotype group, with lower carotene intake: OR 0.39 (0.21–0.71) P interaction = 0.005
Loh 2010 [53]
221 (886) 9
Phyto-oestrogen intake not associated with colorectal cancer among men.
Among women:
Enterolactone intake: OR 0.33 (0.14–0.74); P trend = 0.008
Total enterolignans intake: OR 0.32 (0.13–0.79); P trend = 0.013
Secoisolariciresinol intake: OR 1.60 (0.96–2.69); P trend = 0.074
Ward 2010 [59]
1202 (518,798) 6.1 Participants with 25(OH)D levels in the highest quintile had an HR of 0.69 (0.50–0.93) for colorectal cancer mortality. Fedirko 2012 [46]
1372 (384,375) 12.0 Incidence rate ratio of distal colon cancer of plasma total alkylresorcinols (highest vs. lowest quartile): IRR 0.48 (0.28–0.83). Kyrø 2014 [49]
1399 (520,049) 4.5
An association was observed between higher prediagnostic plasma retinol concentration and a lower risk of colon cancer (highest vs. lowest
quartile): IRR 0.63 (0.46–0.87) P trend = 0.01. Dietary b-carotene showed an inverse association with colon cancer (highest vs. lowest quartile):
OR 0.69 (0.52–0.94) P trend = 0.02. Dietary vitamin C was inversely associated with risk of distal colon cancer (highest vs. lowest quartile): OR
0.60 (0.39–0.93) P trend = 0.02. Dietary vitamin E showed an inverse association with risk of distal colon cancer (highest vs. lowest quartile): OR
0.65 (0.42–0.99) P trend = 0.04.
Leenders 2014 [48]
1367 (NR) 3.7
Plasma methionine: OR 0.79 (0.63–0.99); P trend = 0.05
Plasma choline: OR 0.77 (0.60–0.99); P trend = 0.07
Plasma betaine: OR 0.85 (0.66–1.09); P trend = 0.06
Nitter 2014 [50]
966 (520,482) 3.9 Higher selenium concentrations were associated with a non-significant lower colorectal cancer risk (per 25 lg/L increase): IRR 0.92 (0.82–1.03) Hughes 2015 [60]
421 (46,297) 11.0 Glycemic index (highest vs. lowest category): RR 1.35 (1.03–1.78) P trend = 0.031 Sieri 2015 [33]
434 (44,758) 11.28
No significant association between dietary total antioxidant capacity and colorectal cancer: HR 0.88 (0.65–1.19) highest category vs. lowest;
P trend = 0.353
Dietary total antioxidant capacity in colon cancer (highest vs. lowest tertile): HR 0.63 (0.44–0.89) P trend = 0.008
Dietary total antioxidant capacity in rectal cancer (highest vs. lowest tertile): HR 2.48 (1.32–4.66) P trend = 0.007
Intakes of vitamin C, vitamin E, and ß-carotene not significantly associated with colorectal cancer risk.
Vece 2015 [61]
4517 (472,795) 11.3
Nutrient pattern characterised by high intakes of vitamins and minerals: HR 0.94 (0.92–0.98) per 1 SD.
Pattern characterised by total protein, riboflavin, phosphorus and calcium: HR 0.96 (0.93–0.99) per 1 SD.
The remaining two patterns were not significantly associated with colorectal cancer risk.
Moskal 2016 [62]






(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
966 (NR) NR
Circulating concentration of copper (highest vs. lowest quintile): OR 1.50 (1.06–2.13) P trend = 0.02
Circulating concentration of zinc (highest vs. lowest quintile): OR 0.65 (0.43–0.97) P trend = 0.07
Ratio of copper/zinc (highest vs. lowest quintile): OR 1.70 (1.20–2.40) P trend = 0.0005
Stepien 2017 [52]
4517 (472,795) 11
No association between total flavonoid intake and the risk of overall colorectal cancer or any subtype.
Total dietary flavonoid intake (highest vs. lowest quintile): HR 1.05 (0.93–1.18) P trend = 0.58
No association with any intake of individual flavonoid subclasses.
Zamora-Ros 2017 [63]
5991 (470,169) 13.9 Total dietary polyphenol intake (as a continuous variable) in women: HR 1.06 (0.99–1.14)Total dietary polyphenol intake (as a continuous variable) in men: HR 0.97 (0.90–1.11) Zamora-Ros 2018 [64]
1043 (518,957) 8.3
Results for colorectal cancer mortality associated with deficient relative to sufficient 25(OH)D concentrations were:
HR 2.24 (1.44–3.49) among cases with the vitamin D-binding protein isoform.
HR 0.94 (0.68–1.22) among cases without vitamin D-binding protein.
Gibbs 2020 [45]
1608 (NR) 7.7 Fatty acids: OR 0.51 (0.29–0.90) per unit increase Endogenous metabolites: OR 0.62 (0.50–0.78) per unit change. Rothwell 2020 [51]
HR: hazard ratio; IRR: incidence rate ratio; NR: not reported; OR: odds ratio; RR: risk ratio.
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3.3. Breast Cancer
The number of included studies on breast cancer was 41 (Table 2), with a mean
follow-up (years) of 10.0 ± 3.0.
Wholegrains, vegetables and fruit: Low consumption of fruit and vegetables combined
was associated with a higher risk of breast cancer: HR of 1.76 (1.10–2.82) [65]. The isolated
intake of vegetables was also associated with a lower risk (highest vs. lowest quintile):
HR 0.87(0.80–0.94) [66], and HR 0.65 (0.53–0.81) [67]. According to subtypes of vegetables,
protective effects were found (highest vs. lowest quintile) [67]: HR 0.70 (0.57–0.86) for leafy
vegetables; HR 0.75 (0.60–0.94) for fruiting vegetables; and HR 0.82 (0.66–1.01) for raw
tomatoes. Conversely, a study did not show associations between vegetable or fruit intake
and breast cancer risk [68]. Higher intakes of total dietary fibre and fibre from vegetables
were also associated with a lower risk of breast cancer: HR 0.95 (0.89–1.01), and HR 0.90
(0.84–0.96), respectively; but not with fibre from fruit, cereals, or legumes [69].
Meat, fish, dairy products, and preservation/processing of foods: There were no
associations with the intake of fish [70], meat intake [53,71], and calcium intake [72]. An
association was only shown between high risk of breast cancer and low consumption of
fatty fish: HR 1.80 (1.17–2.78) [65].
Diet patterns: The relationship between breast cancer and dietary profiles was also
studied [36,73–75]. The Mediterranean diet was found to protect against breast cancer
(highest vs. lowest score): HR 0.94 (0.88–1.00) [74]. In contrast, a higher score in the
FSA-NPS DI was associated with a higher risk of postmenopausal breast cancer (highest vs.
lowest quintile): HR 1.08 (1.00–1.16) [36].
Alcoholic and non-alcoholic drinks: The risk of breast cancer increases with alcohol
intake: HR 1.05 (1.03–1.07) [76], HR 1.04 (1.03–1.06) [77], HR 1.74 (1.14–2.68) [65] and TE
1.17(1.01–1.35) [78], among others. Particularly, in the consumption of beer/cider and
wine (for 1 SD increment), the risk of breast cancer was HR 1.05 (1.03–1.06) and HR 1.04
(1.02–1.06), respectively [76]. Other drinks showed protective effects on breast cancer.
Caffeinated coffee intake was associated with lower risk of postmenopausal breast cancer
(highest vs. lowest consumption): HR 0.90 (0.82–0.98) [79]. For every 100 ml increase
in caffeinated coffee intake, the risk of ER-PR- breast cancer was lower: HR 0.96 (0.93–
1.00) [79]. Tea intake [79] and total, sugar-sweetened, and artificially sweetened soft drink
consumption [44] were not associated with breast cancer.
Other dietary exposures: Diet rich in β-carotene, riboflavin, thiamine, folate, fibre, iron,
calcium, magnesium, potassium, phosphorus, vitamins C and vitamin B6 was associated
with a lower risk of breast cancer [80]: HR 0.89 (0.83–0.95). A-carotene and b-carotene had
protective effects on oestrogen-receptor–negative breast tumours risk (highest vs. lowest
quintile) [81]: OR 0.61 (0.39–0.98), and OR 0.41 (0.26–0.65), respectively. Regarding the
relationship between breast cancer and fatty acids, the risk of breast cancer increased with
increasing dietary total industrial trans fatty acids intake [82] and levels of total trans-
MUFAs [83]: HR 1.14 (1.06–1.23), and OR 1.75 (1.08–2.83), respectively. Specifically with
the levels of trans-palmitoleic acid [83], elaidic acid [82], and conjugated linoleic acid [82]:
OR 2.24 (1.30–3.86), HR 1.14 (1.06–1.23), and HR 1.11 (1.03–1.20), respectively. Palmitoleic
acid was associated: OR 1.37 (1.14–1.64) [84], and HR 1.08 (1.01–1.16) [82]. In addition, a
higher dietary glycaemic load was associated with a higher risk factor of breast cancer: HR
1.36 (1.02–1.82) [85], and RR 1.45 (1.06–1.99) [33,86].
3.4. Lung Cancer
A total of 11 studies on lung cancer were included (Table 3), with a mean follow-up
(years) of 8.7 ± 4.5.
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Table 2. Evidence synthesis of the association between diet and breast cancer in the EPIC study.




(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
3659 (281,867) 5.4
No significant associations between vegetable or fruit intake and breast cancer risk (highest vs. lowest quintile):
Total vegetable intake: RR 0.98 (0.84–1.14) P trend = 0.65
Total fruit intake: RR 1.09 (0.94–1.25) P trend = 0.11
Fruit and vegetable juices intake: RR 1.05 (0.92–1.20) P trend = 0.51
van Gils 2005 [68]
1355 (33,116) 7.0 There was a statistically higher risk of breast cancer with:Low consumption of fruit and vegetables: HR 1.76 (1.10–2.82) Engeset 2009 [65]
3747 (110,757) 9.5 Grapefruit intake (≥60 g/day vs. none intake): HR 0.93 (0.77–1.13) P trend = 0.5 Spencer 2009 [87]
1256 (62,699) 9.0
Olive oil intake (highest vs. lowest tertile of g/day/2000 kcal): HR 1.10 (0.92–1.31). There was no association between olive oil and risk of




Inverse association between consumption of all vegetables and breast cancer risk (highest vs. lowest quintile):
Vegetables (all types): HR 0.65 (0.53–0.81) P trend = 0.003
According to subtypes of vegetables, inverse association between increasing consumption of leafy vegetables, fruiting vegetables and raw
tomatoes (highest vs. lowest quintile):
Leafy vegetables all types: HR 0.70 (0.57–0.86) P trend = 0.0001
Fruiting vegetables: HR 0.75 (0.60–0.94) P trend = 0.01
Raw tomatoes: HR 0.82 (0.66–1.01) P = trend 0.03
No association between fruit, overall or by subtypes, and breast cancer risk.
Masala 2012 [67]
11,576 (323,273) 11.5
Breast cancer risk was inversely associated with intakes of total dietary fiber (highest vs. lowest quintile): HR 0.95 (0.89–1.01) P trend = 0.03, and
fiber from vegetables: HR 0.90 (0.84–0.96) P trend = 0.01, but not with fiber from fruit, cereals, or legumes. For vegetable fiber, stronger
associations were observed for oestrogen-receptor–negative and progesterone-receptor–negative (highest vs. lowest quintile): HR 0.74
(0.59–0.93) P trend = 0.01, than for oestrogen-receptor–positive and progesterone-receptor–positive tumors: HR 0.92 (0.81–1.03) P trend = 0.05
Ferrari 2013 [69]
879 (46,297) 11.0 Consumption of vegetables (highest vs. lowest quintile): RR 0.65 (0.53–0.81) P trend = 0.003 Sieri 2015 [33]
10,197 (324,857) 11.5
Vegetable intake was associated with a lower risk of breast cancer (highest vs. lowest quintile): HR 0.87 (0.80–0.94). Although the inverse
association was most apparent for oestrogen and progesterone receptor–negative breast cancer (highest vs. lowest quintile): HR 0.74 (0.57–0.96)
P trend = 0.03, and oestrogen and progesterone receptor–positive breast cancer: HR 0.91(0.79–1.05) P trend = 0.14. Fruit intake was not
significantly associated with total and hormone receptor-defined breast cancer risk.
Emaus 2016 [66]
10,979 (261,119) 15.0
Intakes of fibre (for a 1 SD increment in intake): HR 0.96 (0.94–0.98)
Intakes of apple/pear (for a 1 SD increment in intake): HR 0.96 (0.94–0.99)
Intakes of carbohydrates (for a 1 SD increment in intake): HR 0.96 (0.95–0.98)
Heath 2020 [76]
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(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
4776 (305,895) 6.4
No significant associations between intake of total fish and breast cancer risk were observed (per 10 g fish/day): HR 1.01 (0.99–1.02). When
examining lean and fatty fish separately, a positive significant association only in the highest quintile for fatty fish was found (HR 1.13, 1.01–1.26), but
test for trend was not significant (p = 0.10).
Engeset 2006 [70]
1355 (33,116) 7.0 There was a statistically higher risk of breast cancer with:Low consumption of fatty fish: HR 1.80 (1.17–2.78) Engeset 2009 [65]
7119 (312,707) 8.8 Processed meat consumption (highest vs. lowest quintile): HR 1.10 (1.00–1.20) P trend = 0.07 Pala 2009 [71]
861 (25,639) NR There was no significant joint effect of red and processed meat intake and genotype polymorphism on the risks for breast cancer. Loh 2010 [53]





(years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
585 (37,058) 7.4 Vegetarian population compared to nonvegetarians presented a HR of 0.91 (0.72–1.14) for breast cancer risk (P trend = 0.40) Travis 2008 [75]
240 (14,567) 9.8
Mediterranean diet score (for 2-point increment): HR 0.88 (0.75–1.03) P trend = 0.12
Mediterranean diet score in premenopausal women (for 2-point increment): HR 1.01 (0.80–1.28)
Mediterranean diet score in postmenopausal women (for 2-point increment): HR 0.78 (0.62–0.98)
Trichopoulou 2010 [73]
10,225 (324,837) 11.0
The adapted relative Mediterranean diet was inversely associated with the risk of breast cancer overall and in postmenopausal women
(highest vs. lowest score): HR 0.94 (0.88–1.00) P trend = 0.048 and HR 0.93 (0.87–0.99) P trend = 0.037, respectively.
The association was more pronounced in oestrogen and progesterone receptor negative tumors: HR 0.80 (0.65–0.99) P trend = 0.043.
Buckland 2013 [74]
12,063 (421,701) 15.3 A higher FSAm-NPS DI score (lower nutritional quality diet) was associated with a higher risk of postmenopausal breast cancer(highest vs. lowest quintile): HR 1.08 (1.00–1.16) P trend = 0.03 Deschasaux 2018 [36]




(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
4285 (270,403) 6.4 Alcohol intake (per 10 g/d increase): IRR 1.03 (1.01–1.05) Tjønneland 2007 [89]
1355 (33,116) 7.0 There was a statistically higher risk of breast cancer with:High alcohol consumption: HR: 1.74 (1.14–2.68) Engeset 2009 [65]
861 (25,639) NR There was no evidence of a significant interaction between MGMT Ile143Valpolymorphism and alcohol on breast cancer risk. Loh 2010 [53]
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(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
10,198 (324,862) 11.0
Caffeinated coffee intake was associated with lower risk of postmenopausal breast cancer (high vs. low consumption):
HR 0.90 (0.82–0.98) P trend = 0.029.
For every 100 ml increase in caffeinated coffee intake, the risk of oestrogen and progesterone receptor–negative breast cancer was lower:
HR 0.96 (0.93–1.00).
Non-consumers of decaffeinated coffee had lower risk of postmenopausal breast cancer compared to low consumers: HR 0.89 (0.80–0.99)
P trend = 0.128. Exclusive decaffeinated coffee consumption was not related to postmenopausal breast cancer risk, compared to any
decaffeinated-low caffeinated intake: HR 0.97 (0.82–1.14), or to no intake of any coffee: HR 0.96 (0.82–1.14). Caffeinated and decaffeinated coffee
were not associated with premenopausal breast cancer. Tea intake was neither associated with pre- nor post-menopausal breast cancer.
Bhoo-Pathy 2015 [79]
11,576 (323,274) 11.0 Average daily alcohol intake at baseline (per 10 g/day): HR 1.04 (1.03–1.06) p value < 0.001Significant increasing trends were observed between alcohol intake and tumors. Romieu 2015 [77]
672 (14,338) 14.8 Alcohol consumption higher than 10 g/day: HR 1.30 (1.09–1.54) P trend = 0.007 Masala 2017 [90]
11,576 (323,274) 11.0 For subjects with low intake of fiber (<18.5 g/day), the risk of breast cancer per 10g/day of alcohol intake: HR 1.06 (1.03–1.08). Romieu 2017 [91]
NR (321,081) 16.4 Total, sugar-sweetened, and artificially sweetened soft drink consumption was not associated with risk of deaths from breast cancer. Mullee 2019 [44]
430 (359,570) 14.0 Alcohol intake was positively associated with overall breast cancer risk and specifically with oestrogen-receptor-positive tumours withrespectively: TE 1.17(1.01–1.35) and TE 1.36(1.08–1.70) for a 1-SD deviation increase of intake. Assi 2020 [78]
10,979 (261,119) 15.0
Intake of alcohol (for a 1 SD increment in intake): HR 1.05 (1.03–1.07)
Intake of beer/cider (for a 1 SD increment in intake): HR 1.05 (1.03–1.06)






(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
838 (65,041) 3.4 Fat intake (highest vs. lowest quartile): RR 1.37 (0.99–1.89) Thiebaut 2001 [92]
280 (15,275) 5.2 Highest intake for isoflavones and lignans (highest vs. lowest quintile): HR 0.98 (0.65–1.48) and HR 0.70 (0.46–1.09), respectively. Keinan-Boker 2004 [93]
363 (19,571) 7.0
The SIn-7 (the ratio between palmitic acid and palmitoleic acid) was inversely associated with breast cancer risk (highest vs. lowest quintile):
OR 0.66 (0.41–1.05) P trend = 0.031
For total trans-MUFAs (highest vs. lowest quintile): OR 1.75 (1.08–2.83) P trend = 0.018. We found an increased risk of breast cancer with
increasing levels of trans-palmitoleic acid and elaidic acid: OR 2.24 (1.30–3.86) P trend = 0.0016, and OR 1.45 (0.90–2.33) P trend = 0.12, respectively.
We also observed a trend toward increased risk of breast cancer associated with increasing levels of trans-linoleic acid: OR 1.55 (0.91–2.63)
P trend = 0.10
No significant association was found with either cis-MUFAs, palmitoleic or oleic acids, or cis -linoleic acid.
Chajès 2008 [83]
7119 (312,707) 8.8 High saturated fat intake (highest vs. lowest quintile): HR 1.13 (1.00–1.27) P trend = 0.038 Sieri 2008 [94]






(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
585 (37,058) 7.4 Moderate isoflavone intake (median intake 10.8 mg/day): HR 1.08 (0.85–1.38) P trend = 0.65High isoflavone intake (median intake 31.6 mg/day): HR 1.17 (0.79–1.71) P trend = 0.36 Travis 2008 [75]
366 (19,652) 7
No significant associations between breast cancer risk and serum carotenoids, tocopherols and retinol (highest vs. lowest quintile):
Serum carotenoids: OR 0.74 (0.47–1.16) P trend = 0.38
Tocopherols: OR 0.68 (0.41–1.10) P trend = 0.26
Retinol: OR 0.85 (0.53–1.35) P trend = 0.34
Maillard 2010 [95]
7502 (338,493) 8.8
Dietary intake of b-carotene, vitamin C and E (highest vs. lowest quintile):
In premenopausal women: HR 1.04 (0.85–1.27), HR 1.12 (0.92–1.36) and HR 1.11 (0.84–1.46), respectively.
In postmenopausal women: HR 0.93 (0.82–1.04), 0.98 (0.87–1.11) and 0.92 (0.77–1.11) respectively.
High intake of b-carotene and vitamin C in postmenopausal women using exogenous hormones (highest vs. lowest quintile): HR 0.79
(0.66–0.96) P trend = 0.06, and HR 0.88 (0.72–1.07) P trend = 0.05, respectively.
Overall, dietary intake of b-carotene, vitamin C and E not related to breast cancer risk in neither pre- nor postmenopausal women.
Nagel 2010 [96]
244 (941) 9.0 Phytoestrogen intake not associated with breast cancer among women. Ward 2010 [59]
11,576 (323,273) 11.5
In postmenopausal women with oestrogen-receptor–negative breast cancer:
Glycemic load (highest vs. lowest quintile): HR 1.36 (1.02–1.82) P trend = 0.010
Carbohydate intake (highest vs. lowest quintile): HR 1.41 (1.05–1.89) P trend = 0.009
Further stratification by progesterone receptor status showed slightly stronger associations with ER-/PR- breast cancer (highest vs. lowest
quintile): HR 1.48 (1.07–2.05) P trend = 0.010 for glycemic load, and HR 1.62 (1.15–2.30) P trend = 0.005 for carbohydrates.
Romieu 2012 [85]
7760 (312,225) 8.8 Vitamin D intake (highest vs. lowest quintile): HR 1.04 (0.94–1.14) Abbas 2013 [72]
879 (25,187) 11.0 High dietary glycemic load (highest vs. lowest quintile): RR 1.45 (1.06–1.99) P trend = 0.029 Sieri 2013 [86]
11,576 (323,274) 11.5
Total flavonoids intake (highest vs. lowest quintile): HR 0.97 (0.90–1.04) P trend = 0.591
Isoflavones (highest vs. lowest quintile): HR 1.00 (0.91–1.10) P trend = 0.734
Total lignans intake (highest vs. lowest quintile): HR 1.02 (0.93–1.11) P trend = 0.469
Zamora-Ros 2013 [97]
11,575 (356,418) 11.5
An inverse association was observed between dietary folate and breast cancer risk (highest vs. lowest quintile): HR 0.92 (0.83–1.01) P trend =
0.037.
In premenopausal women, we observed a statistically significant trend towards lower risk in oestrogen-receptor-negative breast cancer and
progesterone-receptor-negative breast cancer (highest vs. lowest quintile): HR 0.66 (0.45–0.96) P trend = 0.042, and HR 0.70 (0.51–0.97) P trend =
0.021, respectively.
A reduction in breast cancer risk was observed when comparing the highest with the lowest dietary folate tertiles in women having a high (>12
alcoholic drinks/week) alcohol intake: HR 0.86 (0.75–0.98).
de Batlle 2015 [98]
11,782 (333,376) 6.0 Among postmenopausal women, an intake of lignans was related to a lower risk of dying from breast (highest vs. lowest quartile): HR 0.72(0.53–0.98). We found no association for other polyphenol classes. Kyrø 2015 [99]
879 (46,297) 11.0 Glycemic load (highest vs. lowest category): RR 1.45 (1.06–1.99) P trend = 0.029 Sieri 2015 [33]






(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
11,576 (323,274) 11.5
A pattern rich in nutrients found in animal foods loading on cholesterol, protein, retinol, vitamins B12, and D was not associated with BC risk.
Diet rich in β-carotene, riboflavin, thiamin, vitamins C and B6, fibre, Fe, Ca, K, Mg, P and folate, was inversely associated with BC risk (highest
vs. lowest quintile): HR 0.89 (0.83–0.95) P trend < 0.01
Assi 2016 [80]
1502 (519,966) 13.0 A-carotene and b-carotene were inversely associated with risk of oestrogen-receptor–negative breast tumors (highest vs. lowest quintile): OR0.61 (0.39–0.98), and OR 0.41 (0.26–0.65), respectively. Bakker 2016 [81]
2982 (516,120) 11.5
A high level of palmitoleic acid (highest vs. lowest quartile): OR 1.37 (1.14–1.64) P trend = 0.0001
Levels of industrial trans-fatty acids were positively associated with oestrogen-receptor–negative tumors (highest vs. lowest tertile): OR
2.01(1.03–3.90) P trend = 0.047
No significant association was found between n-3 polyunsaturated fatty acids and breast cancer risk, overall or by hormonal receptor.
Chajès 2017 [84]
2491 (365,412) 11.5
Plasma levels of folate and vitamin B12 not significantly associated with the risk of breast cancer.
Vitamin B12 status and breast cancer risk in women consuming above the median value of alcohol intake (highest vs. lowest quartile): OR 1.26
(1.00–1.58) P trend = 0.05
Vitamin B12 status with breast cancer risk in women with plasma folate levels below the median value (highest vs. lowest quartile): OR 1.29
(1.02- 1.62) P trend = 0.03
Matejcic 2017 [100]
13,241 (305,366) 8.1
Dietary total industrial trans fatty acids intake (highest vs. lowest quintile): HR 1.14 (1.06–1.23) P trend = 0.001
Elaidic acid intake (highest vs. lowest quintile): HR 1.14 (1.06–1.23) P trend = 0.001
Dietary total ruminant trans fatty acids intake (highest vs. lowest quintile): HR 1.09 (1.01–1.17) P trend = 0.015
Conjugated linoleic acid intake (highest vs. lowest quintile): HR 1.11 (1.03–1.20) P trend = 0.001
Palmitelaidic acid intake: HR 1.08 (1.01–1.16) P trend = 0.028
Matta 2021 [82]
HR: hazard ratio; IRR: incidence rate ratio; NR: not reported; OR: odds ratio; RR: risk ratio; TE: total effects.
Nutrients 2021, 13, 3582 17 of 33
Wholegrains, vegetables and fruit: The combination of eating fruits and vegetables
was associated with a lower lung cancer risk (per 100 g/day increase of intake): HR of
0.94 (0.89–0.99) [101]. Fruit consumption also protects against lung cancer risk (highest vs.
lowest quintile): HR 0.75 (0.49–0.96) [102], and HR 0.60 (0.46–0.78) [103]. Lung cancer risk
decreased with higher vegetable consumption (per 100 g/day increase) in one study: HR
0.92 (0.85–0.99) [102]. Conversely, two studies did not show associations between vegetable
consumption and lung cancer [101,103].
Meat, fish, dairy products, and preservation/processing of foods: There were no con-
sistent associations between meat and fish consumption and the risk of lung cancer [104].
Diet patterns: Higher scores in the FSA-NPS DI were associated with a higher lung
cancer risk (highest vs. lowest quintile): HR 1.26 (1.06–1.51) [36].
Alcoholic and non-alcoholic drinks: Neither ethanol intake at recruitment nor mean
lifetime ethanol intake was associated with lung cancer [105].
Other dietary exposures: A lower risk for lung cancer was observed for elevated serum
levels of B6 and for serum methionine (fourth vs. first quartile): OR 0.44 (0.33–0.60), and
OR 0.52 (0.39–0.69), respectively [106]. Above-median levels of both were associated with a
lower lung cancer risk overall: OR 0.41 (0.31–0.54) [106], as well as separately among never,
former and current smokers: OR 0.36 (0.18–0.72), OR 0.51 (0.34–0.76), and OR 0.42 (0.27–
0.65), respectively [106]. Finally, vitamin C concentration, vitamin K2 intake and haem iron
intake (highest vs. lowest categories) were associated with the risk of lung cancer: HR 0.57
(0.41–0.81) [107], HR 0.38 (0.20–0.71) [108], and HR 1.16 (1.02–1.32) [109], respectively.
3.5. Prostate Cancer
Twenty-five studies on prostate cancer were selected (Table 4), with a mean follow-up
(years) of 9.4 ± 3.8.
Wholegrains, vegetables and fruit: No associations between fruits and vegetables
consumption and prostate cancer risk were observed in one study [111]. However, these
results were later disconfirmed in another study that showed protective associations with
the consumption of fruits (highest vs. lowest quintile): HR 0.91 (0.83–0.99) [112]. Overall,
there was no association between dietary fibre intake (total, cereal, fruit or vegetable fibre)
and prostate cancer risk [113].
Meat, fish, dairy products, and preservation/processing of foods: There were no
associations between prostate cancer and the intake of dairy products, fish, fat from red
meat, and dietary fat [114]. However, there was an association between the risk of high-
grade prostate cancer and the intakes of total, monounsaturated, and polyunsaturated
fats [114]. For each 10% increase in the observed intake of total fat, the risk of high-grade
prostate cancer decreased: HR 0.83 (0.72–0.95) [114]. Each 5% increase in monounsaturated
and polyunsaturated fat intake was associated with a lower risk of high-grade prostate
cancer: HR 0.82 (0.70–0.97) and HR 0.77 (0.62–0.97), respectively [114]. Higher fat intake
from dairy products was also associated with lower risk of localized prostate cancer [114]:
HR 0.92 (0.86–0.99) and HR 0.90 (0.82–0.99), for the observed and calibrated intakes,
respectively. In contrast, yoghurt intake, total dietary calcium intake, calcium intake and
protein intake from dairy products were associated with an increased risk of prostate cancer
(highest vs. lowest quintile): HR 1.17 (1.04–1.31), HR 1.17 (1.00–1.35), HR 1.18 (1.03–1.36),
and HR 1.22 (1.07–1.41), respectively [115].
Diet patterns: One study found a borderline association between a higher score in the
FSA-NPS DI and a higher risk of prostate cancer (highest versus lowest quintile): HR 1.07
(0.98–1.17) [36].
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Table 3. Evidence synthesis of the association between diet and lung cancer in the EPIC study.




(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
860 (477,161) NR Fruit consumption (highest vs. lowest quintile): HR 0.60 (0.46–0.78) P trend = 0.0099No association between vegetable consumption or vegetable subtypes and lung cancer risk. Miller 2004 [103]
1126 (477,464) 6.4
Fruit consumption was significantly inversely associated with lung cancer risk (highest vs. lowest quintile): HR 0.75 (0.49–0.96).
Lung cancer risk significantly decreased with higher vegetable consumption (per 100 g/day increase in vegetable intake): HR 0.90 (0.81–0.99) in
smokers and HR 0.92 (0.85–0.99) overall.
Linseisen 2007 [102]
1830 (476,705) 8.7
A 100 g/day increase in fruit and vegetables consumption was associated with a reduced lung cancer risk: HR 0.94 (0.89–0.99).
A 100 g/day increase in fruit consumption was associated with a reduced lung cancer risk: HR 0.94 (0.88–1.01).
A 100 g/day increase in vegetables consumption was associated with a reduced lung cancer risk: HR 0.94 (0.83–1.07).
Büchner 2010 [101]




(Years) Results, Relative risk (95% Confidence Interval (CI)) Reference
1822 (476,199) 8.7
There were no consistent associations between meat consumption and the risk of lung cancer:
Red meat (per 50 g intake/day): RR 1.06 (0.89–1.27)
Processed meat (per 50 g g/day): RR 1.13 (0.95–1.34)






(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
3654 (421,701) 15.3 A higher FSAm-NPS DI score (lower nutritional quality diet) was associated with a higher lung cancer risk in men and women (highest vs.lowest quintile): HR 1.26 (1.06–1.51) P trend = 0.02, and HR 2.33 (1.23–4.43) P trend = 0.008, respectively. Deschasaux 2018 [36]




(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference





(Years) Results, Relative risk (95% Confidence Interval (CI)) Reference
899 (384,848) NR
A lower risk for lung cancer was seen for elevated serum levels of B6 and for serum methionine (fourth vs. first quartile): OR 0.44 (0.33–0.60) P
trend < 0.000001, and OR 0.52 (0.39–0.69) P for trend <0.000001, respectively.
Above-median levels of both were associated with a lower lung cancer risk overall: OR 0.41 (0.31–0.54), as well as separately among never,
former and current smokers: OR 0.36 (0.18–0.72), OR 0.51 (0.34–0.76), and OR 0.42 (0.27–0.65), respectively.
Johansson 2010 [106]
128 (22,585) 10.2 Dietary intake of vitamin K2 (highest vs. lowest quintile): HR 0.38 (0.20–0.71) P trend = 0.002 Nimptsch 2010 [108]






(Years) Results, Relative risk (95% Confidence Interval (CI)) Reference
892 (1748) 5.2 PA/(pyridoxal þ PLP) levels: OR 1.52 (1.27–1.81) P < 0.001 Zuo 2018 [110]
3914 (15,443) 12.0 Plasma vitamin C concentration (highest vs. lowest quartile): HR 0.57 (0.41–0.81) Myint 2019 [107]
3731 (413,015) 13.9
Haem iron intake (as a continuous variable): HR 1.03 (1.00–1.07) per 0.3 mg/1000 kcal
Haem iron intake (highest vs. lowest quintile): HR 1.16 (1.02–1.32) P trend = 0.035
Non-haem iron intake (as a continuous variable): HR 0.96 (0.92–1.00) per 1.2 g/1000 kcal
Non-haem iron intake (highest vs. lowest quintile): HR 0.90 (0.79–1.02) P trend = 0.068
Total iron intake (as a continuous variable): HR 0.98 (0.94–1.02) per 1.3 g/1000 kcal
Total iron intake (highest vs. lowest quintile): HR 0.95 (0.84–1.07) P trend = 0.20
Ward 2019 [109]
HR: hazard ratio; NR: not reported; OR: odds ratio; RR: risk ratio.
Table 4. Evidence synthesis of the association between diet and prostate cancer in the EPIC study.




(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
1104 (129,440) 4.8
No significant associations between fruit and vegetable consumption and prostate cancer risk were observed (highest vs. lowest quintile):
Total fruits: RR 1.06 (0.84–1.34)
Total vegetables: RR 1.00 (0.81–1.22)
Total fruits and vegetables combined: RR 1.00 (0.79–1.26)
Key 2004 [111]
2747 (139,843) 8.7
Overall, no association between dietary fiber intake (total, cereal, fruit or vegetable fiber) and prostate cancer risk, although calibrated intakes of
total fiber and fruit fiber were associated with non-statistically significant reductions in risk (per 10 g/day): IRR 0.91 (0.81–1.02) P trend = 0.12
and IRR 0.95 (0.89–1.00) P trend = 0.06, respectively.
Suzuki 2009 [113]
7036 (135,200) 13.9 Total fruit intake (highest vs. lowest quintile): HR 0.91 (0.83–0.99) P trend = 0.01Citrus fruits intake (highest vs. lowest quintile): HR 0.94 (0.86–1.02) P trend = 0.01 Perez-Cornago 2017 [112]
2727 (139,793) 8.7
Yoghurt intake was associated with an increased risk (highest vs. lowest quintile): HR 1.17 (1.04–1.31) P trend = 0.02, but there was no evidence
of an association with intakes of milk and milk beverages or cheese.
Total protein intake was not positively associated with increased risk (highest vs. lowest quintile): HR 1.17 (0.96–1.44) P trend = 0.07.
Protein from dairy foods was significantly associated with an increased risk (highest vs. lowest quintile): HR 1.22 (1.07–1.41) P trend = 0.02.
Total dietary calcium intake and calcium intake from dairy foods were also associated with an increased risk (highest vs. lowest quintile): HR
1.17 (1.00–1.35) P trend = 0.01 for total dietary calcium, and HR 1.18 (1.03–1.36) P trend = 0.02 for dairy calcium.
Calcium intake from nondairy foods was not associated with risk.
An increment of 35 g day−1 dairy protein was associated with an HR of 1.32 (1.01–1.72) P trend = 0.04, and increments of 0.3 g day−1 of total
calcium and dairy calcium were associated with HR of 1.09 (1.01–1.16) P trend = 0.02, and HR 1.07 (1.00–1.14) P trend = 0.04, respectively.
Allen, Key 2008 [115]
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Table 4. Cont.




(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
2727 (139,793) 8.7
There were no significant associations between prostate cancer risk and fat from red meat, dairy products, and fish.
There was a significant inverse relation between fat from dairy products and risk of localized prostate cancer (each 5% increase in energy from
dairy fat): HR 0.92 (0.86–0.99) and HR 0.90 (0.82–0.99), for the observed and calibrated intakes, respectively.
There was no significant association between dietary fat (total, saturated, monounsaturated, and polyunsaturated fat and the ratio of
polyunsaturated to saturated fat) and risk of prostate cancer:
Total fat intake (highest vs. lowest quintile): HR 0.96 (0.84–1.09) P trend = 0.155.
There was a significant inverse association between the observed and calibrated intakes of total, monounsaturated, and polyunsaturated fats
and the risk of high-grade prostate cancer:
For each 10% increase in the observed intake of total fat, the risk of high-grade prostate cancer decreased: HR 0.83 (0.72–0.95).
Each 5% increase in monounsaturated and polyunsaturated fat intake was associated with a lower risk of high-grade prostate cancer: HR 0.82
(0.70–0.97) and HR 0.77 (0.62–0.97), respectively.
Crowe, Key 2008 [114]





(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
6745 (421,701) 15.3 A higher FSAm-NPS DI score (lower nutritional quality diet) score was associated with a borderline significant higher risk of prostate cancer(highest vs. lowest quintile): HR 1.07 (0.98–1.17) P trend = 0.04 Deschasaux 2018 [36]




(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
630 (NR) 3.4 Insulin-like growth factor I serum concentration (highest vs. lowest third): OR 1.39 (1.02–0.89) Allen 2007 [122]
2655 (139,952) 8.7
Neither alcohol consumption at baseline nor average lifetime alcohol consumption was significantly associated with risk for prostate cancer:
Alcohol intake: RR 0.88 (0.72–1.08) highest intake (≥60 g per day) vs. lowest (0.1–4.9 g/d)
Average lifetime alcohol intake: RR 1.09 (0.86–1.39)
Rohrmann 2008 [116]
861 (25,639) NR A higher prostate cancer risk was seen with higher alcohol intake among the MGMTIle143Val polymorphism with the variant genotypecompared to the MGMTIle143Val polymorphism with the common genotype with lower alcohol intake: OR 2.08 (1.21–3.57) P interaction = 0.0009 Loh 2010 [53]
NR (521,330) 16.4 Total, sugar-sweetened, and artificially sweetened soft drink consumption was not associated with risk of death from prostate cancer. Mullee 2019 [44]
7036 (135,160) 14.0
No evidence of association for consumption of total, caffeinated or decaffeinated coffee or tea and risk of total prostate cancer or cancer by stage,
grade or fatality (highest vs. lowest consumers):
Coffee intake for total prostate cancer: HR 1.02 (0.94–1.09)
Tea intake for total prostate cancer: HR 0.98 (0.90–1.07)
Coffee intake for total fatal prostate cancer: HR 0.97 (0.79–1.21)
Tea intake for total fatal prostate cancer: HR 0.89 (0.70–1.13)
Sen 2019 [117]






(Years) Results, Relative Risk (95% Confidence Interval (CI)) Reference
966 (136,035) 6.0 None of the micronutrients examined were significantly associated with prostate cancer risk. The risk of advanced disease (highest vs. lowestquintile of plasma concentrations): IRR 0.40 (0.19–0.88) for lycopene and IRR 0.35 (0.17–0.78) for the sum of carotenoids. Key 2007 [123]
959 (149,041) 11.0 Plasma selenium concentration was not associated with prostate cancer risk (highest vs. lowest quintile): RR 0.96 (0.70–1.31) P trend = 0.25 Allen, Naomi 2008 [124]
962 (152,495) 4.2
An inverse association between palmitic acid and the risk of total, localized, and low-grade prostate cancer (highest vs. lowest quintile): RR 1.47
(0.97–2.23) P trend = 0.032, RR 1.90 (1.03–3.49) P trend = 0.013, and RR 1.93 (1.02–3.64) P trend = 0.045, respectively.
An inverse association between stearic acid and the risk of total and localized prostate cancer (highest vs. lowest quintile): RR 0.77 (0.56–1.06)
P trend = 0.03, and RR 0.60 (0.38–0.94) P trend = 0.014, respectively.
Significant positive associations between myristic, α-linolenic and eicosapentaenoic acids and risk of high-grade prostate cancer: RR 1.79
(0.80–3.98), 1.79 (0.91–3.53), and 2.00 (1.07–3.76), respectively.
Crowe, Allen 2008 [125]
268 (11,660) 8.6
Total menaquinone intake (highest vs. lowest quartile): HR 0.65 (0.39–1.06)
Total menaquinone intake for advanced prostate cancer: HR 0.37 (0.16–0.88) P trend = 0.03
Phylloquinone intake (highest vs. lowest quartile): HR 1.02 (0.70–1.48)
Nimptsch 2008 [118]
250 (11,678) 8.0 Serum ucOC/iOC ratio in advanced-stage prostate cancer (per 0.1 increment): OR 1.38 (1.03–1.86)Serum ucOC/iOC ratio in high-grade prostate cancer (per 0.1 increment): OR 1.21 (1.00–1.46) Nimptsch 2009 [119]
652 (152,805) 4.1 No significant association between 25-hydroxyvitamin D and risk of prostate cancer (highest vs. lowest quintile): OR 1.28 (0.88–1.88) P trend = 0.188 Travis, Crowe 2009 [126]
950 (136,050) 4.2 Plasma concentrations of phyto-oestrogen genistein (highest vs. lowest quintile): RR 0.74 (0.54–1.00) P trend = 0.05 Travis, Spencer2009 [127]
180 (22,585) 10.2 Dietary intake of menaquinone (highest vs. lowest quintile): HR 0.65 (0.44–0.97) P trend = 0.03 Nimptsch 2010 [108]
566 (152,834) 4.8 Plasma phytanic acid concentration: OR 1.27 (1.01–1.60) P trend = 0.04 Price 2010 [121]
248 (11,680) NR Glucosinolate intake (per 10 mg/d increment): OR 0.72 (0.53–0.96) Steinbrecher 2010 [128]
204 (812) 9 Total enterolignans intake: OR 1.19 (0.77–1.82) P trend = 0.44 Ward 2010 [59]
962 (152,495) NR A high score on a factor reflecting a long-chain n23 PUFA pattern (fatty acids) was associated with greater risk of prostate cancer (highest vs.lowest quintile): OR 1.36 (0.99–1.86) P trend = 0.041 Dahm 2012 [129]
4606 (134,399) 10.0
Prostate cancer risk was not associated with intake of nitrosamines (highest vs. lowest quintile): HR 0.91 (0.81- 1.03) for endogenous
Nitrosocompounds, and HR 1.04 (0.95–1.18) for N-Nitrosodimethlyamine. There was also no association with heme iron (highest vs. lowest
quintile): HR 1.00 (0.88–1.39).
Jakszyn 2012 [130]
5916 (117,082) 14.0 Dry cakes/biscuits and butter intakes for low-grade prostate cancer: HR 1.07 (1.03–1.11) P = 0.01Dry cakes/biscuits and butter intakes for aggressive prostate cancer: HR 1.08 (1.04–1.13) P = 0.02 Papadimitriou 2020 [131]
7036 (135,203) 13.9
Butyric acid intake calibrated for advanced stage prostate cancer (for 1 SD increase): HR 1.08 (1.01–1.15) P trend = 0.026
Eicosenoic acid intake calibrated for fatal prostate cancer (for 1 SD increase): HR 1.05 (1.00–1.11) P trend = 0.048
Eicosapentaenoic acid intake calibrated for fatal prostate cancer (for 1 SD increase): HR 1.07 (1.00–1.14) P trend = 0.045
Perez-Cornago 2020 [120]
HR: hazard ratio; IRR: incidence rate ratio; NR: not reported; OR: odds ratio; RR: risk ratio.
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Alcoholic and non-alcoholic drinks: Neither alcohol consumption at baseline nor
average lifetime alcohol consumption was associated with risk for prostate cancer [116].
No evidence of association for consumption of total, caffeinated or decaffeinated coffee or
tea and risk of total prostate cancer or cancer by stage, grade or fatality (highest vs. lowest
consumers) [117]. Neither total, sugar-sweetened, and artificially sweetened soft drink
consumption was associated with risk of death from prostate cancer [44].
Other dietary exposures: There was a protective effect between menaquinone intake
and prostate cancer: HR 0.37 (0.16–0.88) for advanced prostate cancer [118], HR 0.65 (0.44–
0.97) for prostate cancer incidence [108], OR 1.38 (1.03–1.86) for serum undercarboxylated
osteocalcin (ucOC)/intact osteocalcin (iOC) ratio in advanced-stage prostate cancer [119],
and OR 1.21 (1.00–1.46) for serum ucOC/iOC ratio in high-grade prostate cancer [119]. Fatty
acids were a risk factor for prostate cancer: HR 1.08 (1.01–1.15) for butyric acid intake [120],
HR 1.05 (1.00–1.11) for eicosenoic acid intake [120], HR 1.07 (1.00–1.14) for eicosapentaenoic
acid intake [120], and OR 1.27 (1.01–1.60) for plasma phytanic acid concentration [121].
Finally, the serum concentration of insulin-like growth factor I was also a risk factor for
prostate cancer [122].
4. Discussion
Colorectal cancer: Several EPIC studies have found protective effects against colorec-
tal cancer risk of the following diet-related factors: consumption of fish, dietary fibre,
fruits and vegetables, nuts/seeds, dietary calcium, milk, yogurt, circulating vitamin D
concentration, plasma concentrations of vitamins B2 and B6, plasma retinol concentration,
dietary b-carotene, dietary vitamin C, and dietary vitamin E. On the contrary, alcohol and
red and processed meat consumption were associated with a significant increase in col-
orectal cancer risk. Adherence to a traditional Mediterranean diet was strongly associated
with a reduction of colorectal cancer risk, whereas higher FSA-NPS DI scores, i.e., lower
nutritional quality of the diet, and higher DII scores, i.e., a more pro-inflammatory diet,
were particularly associated with higher risks of cancer of the colon-rectum. However, the
associations for the DII scores were more evident in men and not significant in women.
These sex-differences can be due to hormonal influences because oestrogen plays a key
protective role in the pathogenesis of colorectal cancer in women [132]. Therefore, diet
and hormonal components can affect colorectal cancer risk differently in women than in
men [133].
The EPIC study findings are in line with the World Cancer Research Fund/American
Institute of Cancer Research (WCRF/AICR) latest report [9] that concluded that there
is strong evidence to support that consuming foods containing dairy products, dietary
fibre, and dietary calcium decreases the risk of colorectal cancer while consuming alcohol
and red and processed meat increases it. According to this report, there is also limited
evidence supporting that the intake of fish, carotene, vitamin C, and vitamin D might
decrease colorectal cancer risk; however, a recent mendelian randomisation study on
vitamin D and risk of seven cancers concluded that there is limited evidence of a linear
causal relationship between circulating vitamin D concentration and colorectal cancer
risk [134]. Further, ingested red and processed meat is classified following the International
Agency for Research on Cancer (IARC) as a probable human carcinogen (group 2A) and
carcinogen to humans (group 1), respectively [135]. A current review of 45 meta-analyses
also found convincing and biologically plausible evidence for the association between
lower risk of colorectal cancer and higher dietary fibre intake, higher dietary calcium and
yogurt intake, and lower alcohol and red meat intake [136]. The EPIC study findings appear
to be in agreement with the latest systematic review from the WCRF and AICR [8] and a
recent umbrella review of meta-analyses of prospective observational studies [136]. Hence,
they largely support existing cancer prevention recommendations that advise increased
fibre and dairy products intake and limited red meat and alcohol intake to reduce colorectal
cancer risk.
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Breast cancer: The EPIC results showed that intake of vegetables, fruits and veg-
etables, total dietary fibre, fibre from vegetables, and fatty fish protect against breast
cancer, whereas no associations were found for fruit or fibre derived from fruit, cereals,
or legumes. However, one study did not find associations between fruit or vegetable
intake and breast cancer risk [68]. Since these results were obtained during the first years
of EPIC, the relatively short follow-up might not best reflect the true association. Later,
significant associations were found in longer follow-up studies [33,65–67]. Lower breast
cancer risk was associated with adherence to a Mediterranean diet whereas diets with
lower nutritional quality were associated with a higher risk of postmenopausal breast
cancer. Overall, stronger associations were found for progesterone-receptor–negative and
oestrogen-receptor–negative cancer types for vegetable intake, fibre from vegetables, and
Mediterranean diet. Conversely, alcohol intake clearly and strongly increased the risk of
breast cancer regardless of the menopausal status. A diet rich in β-carotene, riboflavin,
thiamine, folate, fibre, iron, calcium, magnesium, potassium, phosphorus, vitamins C and
vitamin B6 protects against breast cancer. In addition, high saturated fatty acids intake,
and high dietary glycaemic load were all significantly associated with a higher risk of
breast cancer.
The EPIC study findings are concordant with the WCRF/AICR third expert report [9]
that concluded that there is strong evidence that consuming alcoholic drinks increases
the risk of breast cancer both in pre- and postmenopausal women. According to the
report, there is also some evidence that the consumption of non-starchy vegetables may
reduce the risk of oestrogen-receptor–negative breast cancer; the consumption of foods
containing carotenoids the risk of breast cancer in general; and the consumption of dairy
products and diets high in calcium the risk of premenopausal breast cancer. The evidence
available for the risk of postmenopausal breast cancer is more limited but points in the same
direction. As seen in the results from the WCRF and AICR [9] and the EPIC study, the role
of dietary factors in the development of breast cancer is not entirely resolved. Alcohol is
the only established dietary risk factor, probably acting by increasing levels of endogenous
oestrogen and other hormones associated with this cancer [137–140]. Findings from a
recent systematic review of dietary patterns and breast cancer risk suggest that patterns
including vegetables, red and processed meats, and that limit saturated fat may reduce
breast cancer risk [141]. The association between saturated fat and breast cancer has been
very controversial over the past years, with some studies such as EPIC supporting a positive
relationship [142,143] and others not finding enough evidence of a relationship [144,145].
More studies are needed to confirm these results and to identify the biological pathways
that may be the reason for the association.
Lung cancer: The effect of diet on lung cancer has been investigated less in the EPIC
study, with only 11 studies reported since 2004. Results from EPIC overall have shown that
intake of fruit and vegetables protects against lung cancer. No consistent associations were
found for meat and fish consumption. A lower nutritional quality of diet was associated
with a higher lung cancer risk in men and women. On the other hand, a decreased risk of
lung cancer was seen for high serum levels of B6 and methionine, even among former and
current smokers. Along the same lines, dietary intake of vitamin C, vitamin K2 and haem
iron were also associated with a lower risk of developing lung cancer.
The EPIC results regarding vitamin C and fruit and vegetables intake are consis-
tent with the epidemiological evidence moderately supporting a decrease in lung cancer
risk [9,146–148]. The WCRF and AICR report also concluded that food and fruits con-
taining retinol, β-carotene or carotenoids probably decrease the risk of lung cancer, while
there is strong evidence that taking high-dose β-carotene supplements increases the risk in
current and former smokers. Vegetable intake might also have a protective role in current
and former smokers, but more evidence is needed, as well as for red and processed meat,
alcoholic drinks, and isoflavones intake. The latest WRCF/AICR report also highlights the
robustly convincing role that drinking water containing arsenic has in increasing the risk
of lung cancer [9]. Unquestionably, more studies are warranted to explore these results, but
Nutrients 2021, 13, 3582 24 of 33
since smoking is the main cause of lung cancer, the most effective measure of prevention
among smokers remains to stop smoking.
Prostate cancer: EPIC studies regarding prostate cancer and its relationship with diet
have yielded controversial results. One study showed protective associations between
consumption of fruits and prostate cancer [112], but no associations were observed with
fruits or vegetables consumption in another study [111]. This may be also due to the
relatively short follow-up in this later study. High total dietary calcium, intake of yoghurt,
and calcium and protein from dairy products were significant associated with a moderate
increase in risk of prostate cancer. However, there was no evidence of association with the
intake of dairy products. Results associated with diets rich in calcium are consistent with
scientific evidence indicating that this association is likely [9]. Some evidence from the
WCRF/AICR report also relates higher intake of dairy products, low plasma vitamin E,
and low plasma selenium concentrations with an increase in the risk of prostate cancer [9].
No consistent associations were found in the EPIC study for diets with lower nutritional
quality, fat from dairy products and fruit and vegetables combined consumption. Overall,
in the EPIC study, there were no associations of intake of dietary fibre, vitamin D, fish,
dietary fat, alcohol, coffee, tea, and soft drinks, with the risk of prostate cancer. However, a
higher risk of prostate cancer was observed with higher intake of alcohol among the O6-
Methylguanine-DNA methyltransferase (MGMT) gene Ile143Val polymorphism carriers
of the variant genotype in comparison with the MGMT Ile143Ile common genotype with
lower alcohol intake [53]. Two mendelian randomisation studies on alcohol intake and the
risk of prostate cancer yielded inconsistent results [149,150].
Results from EPIC might underestimate the role that diet may play in prostate car-
cinogenesis. Prostate cancer aetiology remains largely unknown and increasing evidence
is being gathered supporting the relevant role of dietary factors in the disease [151,152].
According to a recent review, consumption of trans and saturated fatty acids, and food
products such as processed meat contributes to prostate carcinogenesis through the alter-
ation of prostate hormonal regulation, the induction of oxidative inflammation and stress,
and the alteration of growth factor signalling and lipid metabolism. Conversely, a high
consumption of fruits, vegetables, whole grain products, and fish seem to exert protective
and/or therapeutic effects [151].
Biological mechanisms believed to underlie the role of diet in carcinogenesis in general
include cell-cycle regulation, growth factors (such as insulin and insulin-like growth
factors), immunity, inflammation, and angiogenesis [3]. Fruits and vegetables are a rich
source of vitamin C and E, folate, and selenium, which are related to anti-tumorigenic
effects in different cells [153]. Potential mechanisms explaining the effects of red and
processed meat on cancer risk include cooking at high temperatures, which results in
mutagenic potential trough the formation of DNA adducts [9]; some DNA-damaging
mechanisms associated with high haem iron intake [154], and the high salt content of
processed meat that may produce damage to the stomach resulting in inflammation or
atrophy [9], among others. Finally, drinking alcohol can be carcinogenic to some cell types
and genotoxic due to ethanol [155,156], can interfere in DNA repair mechanisms [157], and
produce changes in hormone metabolism [158]. The role of diet in the aetiology of cancer
will continue to be investigated in EPIC, also using tumour molecular pathology and omics
research, including metabolomics, genetics, and the microbiome [3].
The EPIC study findings have contributed to the WRCF/AICR recommendations
about cancer prevention. In comparison with the previous review [8], this updated arti-
cle shows EPIC findings derived from longer follow-up studies that best reflect what is
etiologically relevant. This review compiles novel and stronger evidence that confirms
some weak associations described previously [8], such as the association of fruit and/or
vegetables consumption with colorectal, breast, and prostate cancer, or dietary fibre intake
with colorectal cancer. In the past years, more evidence has accumulated about dietary
patterns (for example, Mediterranean diet, lower nutritional quality diet or inflammatory
score of the diet), and other dietary exposures such as nutritional biomarkers (for example,
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several vitamins, carotenes, or fatty acids). New evidence has emerged regarding yogurt,
milk, and soft drink consumption in relation to colorectal cancer risk; fatty fish and coffee
intake and breast cancer risk; and yogurt and fat intakes with prostate cancer risk. Overall,
this work adds ninety new published articles about colorectal, breast, lung, or prostate
cancer. This reflects the remarkable increase in the available evidence from the EPIC study
in the last ten years (n = 20 vs. n = 110).
The EPIC study has been highly prolific and a major source of evidence regarding the
aetiology of cancer and other chronic diseases. The most relevant strengths of the EPIC
study are its very large sample size, its prospective nature, the availability of blood samples
to explore biomarkers, and the very comprehensive dietary questionnaires, from diverse
European populations with different predominant dietary patterns and a wide variation
in cancer incidence. Nevertheless, the EPIC study also has limitations that could affect its
results. Like in most observational studies, our results are in partly based on self-reported
data that may be subject to misclassification or measurement error in dietary intake.
5. Conclusions
The EPIC study has resulted in numerous high-quality publications about the role
of diet in cancer prevention that help inform public health recommendations, policies,
and strategies. Overall, fruit and vegetable consumption had a protective effect against
colorectal, breast, and lung cancer, whereas only fruit had a protective effect against prostate
cancer. A higher consumption of fish and lower consumption of red and processed meat
were related with a lower risk of colorectal cancer; and higher consumption of fatty fish
with lower risk of breast cancer. Calcium and yogurt intake were found to protect against
colorectal and prostate cancer. Alcohol consumption increased the risk for colorectal and
breast cancer. Finally, adherence to the Mediterranean diet emerged as a protective factor
for colorectal and breast cancer.
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